It is crucial to discuss all potential risks with a healthcare provider before starting treatment with semaglutide
Intramuscular injection delivers IGF-1 LR3 directly into a muscle belly (commonly the deltoid, vastus lateralis, or gluteus)
Semaglutide GLP-1 is a class of drugs called glucagon-like peptide-1 (GLP-1) receptor agonists, which treat type 2 diabetes and obesity
At the same time, glucagon receptor activity is being explored for its role in energy expenditure, lipid oxidation, and thermogenesis
According to Holst these results meant 'There was no longer any doubt: GLP-1 treatment of type 2 diabetes was extremely promising' (Holst 2024)
"This is only done upon the presentation of a valid prescription and with strict adherence to the relevant compounding guidelines." Manufacturers warn against copycat drugs Despite the extreme demand for alternatives, the official manufacturers have warned against taking, making and prescribing unofficial versions of their drugs